HomeAPLS • NASDAQ
add
Apellis Pharmaceuticals Inc
Previous close
$27.51
Day range
$26.78 - $27.71
Year range
$26.75 - $73.80
Market cap
3.34B USD
Avg Volume
2.12M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 199.68M | 110.26% |
Operating expense | 128.08M | 15.00% |
Net income | -37.66M | 69.14% |
Net profit margin | -18.86 | 85.32% |
Earnings per share | -0.29 | 71.75% |
EBITDA | -28.99M | 75.84% |
Effective tax rate | -0.30% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 368.04M | -41.18% |
Total assets | 904.48M | -1.21% |
Total liabilities | 640.16M | 12.27% |
Total equity | 264.33M | — |
Shares outstanding | 121.77M | — |
Price to book | 12.68 | — |
Return on assets | -8.48% | — |
Return on capital | -13.21% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -37.66M | 69.14% |
Cash from operations | -8.34M | 94.45% |
Cash from investing | -90.00K | 75.81% |
Cash from financing | 42.49M | 2,623.53% |
Net change in cash | 34.40M | 123.09% |
Free cash flow | -83.78M | 35.77% |
About
Founded
2009
Headquarters
Website
Employees
704